NASDAQ:MCRB | EBITDA Margin | Seres Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2016-03-31 to 2026-06-30
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-06-30-2799.32%
2026-03-31-5621.79%
2025-12-31-4206.16%
2025-09-30-6106.27%
2023-12-3128.03%
2023-09-30-13839.35%
2023-06-3040.37%
2023-03-3113250.57%
2022-12-31-10.67%
2022-09-30-1665.51%
2022-06-30-5069.08%
2022-03-31-3629.00%
2021-12-31-663.07%
2021-09-3055.16%
2021-06-30-887.63%
2021-03-31-728.27%
2020-12-31-1401.97%
2020-09-30-35523.75%
2020-06-30-363.56%
2020-03-31-327.54%
2019-12-31-329.46%
2019-09-30-316.26%
2019-06-30-86.35%
2019-03-31-340.85%
2018-12-31-193.00%
2018-09-30-233.04%
2018-06-30-613.02%
2018-03-31-699.02%
2017-12-31-912.04%
2017-09-30-23.67%
2017-06-30-884.41%
2017-03-31-801.33%
2016-12-31-789.82%
2016-09-30-137.10%
2016-06-30-907.66%
2016-03-31-720.66%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-11386.31%
2022-12-31-2431.05%
2021-12-31-40.70%
2020-12-31-685.48%
2019-12-31-236.40%
2018-12-31-343.36%
2017-12-31-262.11%
2016-12-31-407.21%